{"gene":"CD69","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":2023,"finding":"Cryo-EM structure of CD69-bound S1PR1 coupled to heterotrimeric Gi complex revealed that the transmembrane helix (TM) of one protomer of the CD69 homodimer contacts S1PR1-TM4, allosterically inducing movement of S1PR1-TMs 5-6 to directly activate the receptor and engage Gi. Mutations at the interface reduced CD69-S1PR1 interactions and receptor internalization. CD69 thus acts in cis as a protein agonist of S1PR1, promoting Gi-dependent S1PR1 internalization, loss of S1P gradient sensing, and inhibition of lymphocyte egress.","method":"Cryo-EM structure determination, mutagenesis of interface residues, receptor internalization assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure with mutagenesis validation and functional receptor internalization assays in a single rigorous study","pmids":["37039481"],"is_preprint":false},{"year":2006,"finding":"CD69 forms a physical complex with S1PR1 (but not the related receptor S1PR3), inhibits S1PR1 chemotactic function, and leads to downmodulation of S1PR1 surface expression. This mechanism operates downstream of IFN-α/β signaling to promote lymphocyte retention in lymphoid organs. CD69-/- cells retained S1PR1 function after IFN-α/β exposure, and S1PR1 crosslinking co-activated a CD69-CD3ζ chimera.","method":"Co-immunoprecipitation, coexpression chemotaxis assays, CD69-/- mouse model with poly(I:C) and LCMV infection, reporter assay with CD69-CD3ζ chimera","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, functional coexpression assays, genetic KO with defined egress phenotype, replicated across multiple stimuli","pmids":["16525420"],"is_preprint":false},{"year":2010,"finding":"CD69 suppresses S1PR1 function through an integral membrane interaction requiring the transmembrane and membrane-proximal domains of CD69 and transmembrane helix 4 of S1PR1. N-linked glycosylation, tyrosine sulfation, and desensitization motifs of S1PR1 are not required. CD69 expression leads to reduction of S1PR1 in cell lysates (likely degradation), and the S1PR1-CD69 complex exhibits a longer S1P binding half-life than S1PR1 alone, suggesting CD69 induces a ligand-bound-like S1PR1 conformation that facilitates internalization. A non-S1PR1-binding CD69 mutant failed to inhibit T cell egress.","method":"Domain-swapping between CD69 and NKRp1A, S1PR1 mutagenesis, radioligand binding assays, T cell egress assays with CD69 mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with domain-swap and mutagenesis of both proteins, multiple orthogonal methods, functional egress validation","pmids":["20463015"],"is_preprint":false},{"year":2016,"finding":"CD69 associates with the aromatic-amino-acid transporter complex LAT1-CD98 (SLC7A5-SLC3A2), regulating its surface expression and uptake of L-tryptophan. This controls intracellular L-Trp-derived AhR activators, thereby governing AhR-dependent IL-22 secretion by γδ T cells and contributing to psoriasis pathogenesis. In vivo administration of L-Trp, an AhR inhibitor, or IL-22 neutralization abrogated differences between CD69-deficient and wild-type mice in skin inflammation.","method":"Co-immunoprecipitation of CD69 with LAT1-CD98, flow cytometry of transporter surface expression, metabolite measurement, CD69-/- mouse model with IL-23-induced psoriasis, in vivo rescue experiments","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP identification of complex, functional KO rescue with multiple orthogonal in vivo and in vitro approaches","pmids":["27376471"],"is_preprint":false},{"year":2010,"finding":"CD69 limits Th17 cell differentiation through association of its cytoplasmic tail with the Jak3/Stat5 signaling pathway. CD69 deficiency in CD4+ T cells leads to enhanced RORγt transcription and IL-17 production. Selective Jak3 inhibition enhanced RORγt transcription, and exogenous IL-2 restored Stat5 phosphorylation and inhibited the enhanced Th17 differentiation in CD69-deficient cells.","method":"Biochemical co-association of CD69 cytoplasmic tail with Jak3/Stat5 (immunoprecipitation), in vitro Th17 differentiation of CD69-/- T cells, Jak3 inhibition, IL-2 rescue experiments, in vivo OVA-specific TCR transgenic and collagen immunization models","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP of CD69 cytoplasmic tail with Jak3/Stat5, pharmacological dissection, and in vivo genetic model, multiple orthogonal methods in single lab","pmids":["20696842"],"is_preprint":false},{"year":2014,"finding":"Galectin-1 was identified as a natural ligand for CD69 on dendritic cells. The interaction is direct, specific, and carbohydrate-dependent, as shown by surface plasmon resonance and anti-CD69 blocking. CD69-galectin-1 interaction mediates the negative effect of galectin-1 on Th17 cell differentiation in both human and mouse T cells.","method":"Pulldown with CD69-extracellular domain fusion protein followed by mass spectrometry, surface plasmon resonance, blocking antibodies, Th17 differentiation functional assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — pulldown + MS identification, SPR affinity measurement, carbohydrate-dependent blocking, functional Th17 assays; single lab but multiple orthogonal methods","pmids":["24752896"],"is_preprint":false},{"year":2015,"finding":"The S100A8/S100A9 complex was identified as a natural ligand for CD69 in human PBMCs. The interaction is glycosylation-dependent: removal of N-linked glycans from CD69 (peptide-N-glycosidase treatment) abolished the association, and removal of sialic acid from CD69 N-glycans reversed Treg cell generation. CD69-S100A8/S100A9 interaction upregulates SOCS3, inhibiting STAT3 signaling and supporting TGF-β secretion, thereby promoting Treg differentiation.","method":"Immunoprecipitation and mass spectrometry, in vitro binding and competition assay, glycomics analysis of CD69, CD69 RNAi knockdown, STAT3 signaling measurement","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — IP-MS identification, in vitro binding confirmation, glycomics, and functional knockdown; single lab","pmids":["26296369"],"is_preprint":false},{"year":1989,"finding":"Cross-linking of CD69 by monoclonal antibody induces prolonged elevation of intracellular Ca2+ primarily through extracellular Ca2+ influx. When combined with PKC activation (by PMA), CD69 stimulation induces IL-2 and IFN-γ gene expression, CD25 upregulation, and IL-2-dependent T cell proliferation. CD69-mediated Ca2+ signal alone cannot activate PKC and cannot trigger cytotoxicity programs.","method":"Anti-CD69 mAb crosslinking, intracellular Ca2+ measurement, cytokine gene expression assay, proliferation assay, cyclosporin A inhibition","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct crosslinking with multiple functional readouts (Ca2+ flux, cytokine expression, proliferation), pharmacological dissection, replicated across T cell subsets","pmids":["2501389"],"is_preprint":false},{"year":1990,"finding":"CD69 is constitutively expressed on human platelets as a phosphorylated disulfide-linked homodimer. Anti-CD69 mAb crosslinking induces platelet aggregation in a dose-dependent manner, associated with Ca2+ influx, platelet degranulation (ATP release), and production of thromboxane B2 and PGE2, indicating activation of arachidonic acid metabolism via cyclooxygenase.","method":"Flow cytometry and biochemical characterization of platelet CD69, anti-CD69 mAb crosslinking aggregation assay, Ca2+ influx measurement, ATP release assay, thromboxane/prostaglandin ELISA","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct crosslinking with multiple orthogonal functional readouts; single lab but rigorous biochemical characterization","pmids":["2388032"],"is_preprint":false},{"year":2002,"finding":"CD69 engagement in IL-2-activated human NK cells leads to rapid and selective activation of the tyrosine kinase Syk (but not ZAP70). Src family kinases (including Lck) are required upstream of Syk activation. Syk and Src kinases control CD69-triggered tyrosine phosphorylation and activation of PLCγ2 and the Rho-family GEF Vav1, which are responsible for CD69-triggered NK cell cytotoxicity.","method":"Anti-CD69 mAb crosslinking in IL-2-activated NK cells and RBL transfectants, immunoprecipitation and kinase activity assays, Src/Syk inhibitors, cytotoxicity assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — biochemical dissection with IP/kinase assays, pharmacological inhibitors, and functional cytotoxicity readout; multiple orthogonal methods in single lab","pmids":["12077230"],"is_preprint":false},{"year":2000,"finding":"CD69 engagement activates extracellular signal-regulated kinases (ERK/MAPK), and this ERK activation is required for CD69-mediated cell degranulation. Co-engagement of the CD94/NKG2-A inhibitory receptor suppresses CD69-triggered ERK activation and thereby inhibits CD69-mediated degranulation in RBL transfectants and NK cell cytotoxicity.","method":"RBL transfectants expressing CD69 ± CD94/NKG2-A, ERK activation assay, degranulation assay, NK cytotoxicity assay with inhibitory receptor co-crosslinking","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ERK activation linked to function, inhibitory receptor interference demonstrated, single lab with multiple readouts","pmids":["10671222"],"is_preprint":false},{"year":1993,"finding":"CD69 cDNA encodes a 199-amino-acid type II membrane glycoprotein with extracellular C-type lectin domain, transmembrane, and intracellular domains. Transient expression of the CD69 cDNA in COS-7 cells recapitulated native CD69 properties. The gene maps to chromosome 12p13-p12 and is a member of the Ca2+-dependent (C-type) lectin superfamily, structurally related to NKG2, NKR-P1, and Ly49 family NK receptors.","method":"PCR-based cDNA cloning from peptide sequences, transient expression in COS-7 cells, somatic cell hybrid DNA analysis, fluorescence in situ hybridization, protein sequence homology analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct cDNA cloning with functional expression validation and chromosomal mapping; foundational structural characterization replicated across subsequent studies","pmids":["8340758"],"is_preprint":false},{"year":1994,"finding":"Constitutively active v-Ha-ras induced CD69 surface expression in Jurkat T cells, and a dominant-negative c-Ha-ras-N17 mutant markedly reduced TCR/CD3-mediated CD69 induction, demonstrating a central role for p21ras activation in TCR/CD3-mediated CD69 expression.","method":"Transfection of constitutively active and dominant-negative Ras constructs in Jurkat cells, GTP-bound Ras immunoprecipitation, AP-1-CAT reporter assay, flow cytometry of CD69 expression","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function Ras constructs with mechanistic readouts (GTP-Ras IP, AP-1 reporter, CD69 surface expression); single lab, multiple orthogonal methods","pmids":["7907294"],"is_preprint":false},{"year":2002,"finding":"Constitutive surface expression of CD69 in transgenic mice caused accumulation of phenotypically and functionally mature thymocytes in the thymic medulla with failure of export to the periphery, correlating with transgene dose and CD69 surface levels. CD69 did not affect T cell maturation, TCR signaling, or thymocyte selection, indicating a specific role in controlling thymocyte egress from the thymus.","method":"CD69 transgenic mouse generation and characterization, flow cytometry of thymic subsets, functional assays for TCR signaling and selection, thymic export quantification","journal":"International immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic gain-of-function with dose-dependent phenotype, negative controls for selection and signaling, well-defined cellular readout","pmids":["12039905"],"is_preprint":false},{"year":2000,"finding":"CD69-/- mice showed largely normal T cell development, selection, NK and CTL cytotoxic activity, but B cell development was affected: the B220hi IgMneg bone marrow pre-B cell compartment was augmented, and CD69 deficiency led to slightly increased IgG2a and IgM responses to immunization.","method":"Gene-targeted CD69-/- mice, flow cytometry of hematopoietic subsets, TCR transgenic selection model, NK and CTL cytotoxicity assays, immunization and antibody measurement","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — comprehensive KO characterization with multiple cell lineages and functional assays across multiple independent experiments","pmids":["10733501"],"is_preprint":false},{"year":1992,"finding":"In neutrophils, CD69 molecules are stored intracellularly (likely in a trans-Golgi structure, based on brefeldin A insensitivity) and are rapidly mobilized to the cell surface upon activation by PMA or fMLP independently of new protein synthesis. CD69 stimulation in neutrophils induces Ca2+ influx and enhances lysozyme release, suggesting a role in granule exocytosis via a Ca2+-dependent mechanism.","method":"Flow cytometry of surface vs. intracellular CD69, cycloheximide and brefeldin A treatment, immunoprecipitation, Ca2+ flux measurement, lysozyme release assay","journal":"Cellular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological inhibitors to define intracellular localization, functional Ca2+ and degranulation readouts; single lab","pmids":["1586955"],"is_preprint":false},{"year":2000,"finding":"Chimeric domain-swap analysis between CD69 and CD23 showed that the neck region (Cys68) is important for CD69 dimerization. The cytoplasmic domain of CD69 independently determines the type of signal transduced (Ca2+-dependent extracellular Ca2+ uptake and TNF-α synthesis), regardless of receptor oligomerization state. CD69 cytoplasmic domain-mediated TNF-α production was additive to FcεRI-mediated TNF-α in mast cells.","method":"CD69/CD23 chimeric receptor construction and functional expression in RBL-2H3 and Jurkat cells, Ca2+ flux measurement, serotonin release assay, TNF-α synthesis assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-swap chimeras with multiple functional readouts; single lab","pmids":["11034393"],"is_preprint":false},{"year":2015,"finding":"CD69 surface expression on skin-infiltrating CD8 T cells (regulated by local antigen stimulation and type I IFNR signaling) coincides with transcriptional downregulation of S1PR1 and is a critical determinant of prolonged T cell retention and local memory T cell formation in peripheral tissues.","method":"Flow cytometry and gene expression analysis of CD8 T cells in skin, CD69-/- mouse model, type I IFNR signaling manipulation, tissue retention and memory formation assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined mechanistic pathway (S1PR1 transcriptional downregulation), multiple regulatory inputs tested, replicated in skin tissue-residency context","pmids":["25624457"],"is_preprint":false},{"year":2018,"finding":"Anti-CD69 mAb treatment attenuated T cell exhaustion and tumor progression in murine breast cancer. CD69 deficiency in tumor-bearing mice showed reduced tumor growth with increased tumor-infiltrating lymphocytes, less T cell exhaustion, and enhanced IFNγ production, indicating CD69 negatively regulates effector function of intratumoral T cells and promotes T cell exhaustion.","method":"CD69-/- mouse tumor model (4T1-luc2 breast cancer), anti-CD69 mAb treatment, flow cytometry of tumor-infiltrating lymphocytes, exhaustion marker analysis, IFNγ production measurement","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO and antibody treatment with defined exhaustion phenotype readout; single lab","pmids":["30085193"],"is_preprint":false},{"year":2023,"finding":"CD69 expression on tumor-specific CD8+ T cells in tumor-draining lymph nodes controls their differentiation by regulating TOX transcription factor expression. CD69 deficiency diminished TOX expression in tumor-specific CD8+ T cells, promoting generation of functional terminally differentiated CD8+ T cells. Anti-CD69 administration combined with anti-PD-1 showed enhanced antitumor effect.","method":"CD69-/- mouse tumor model, flow cytometry and gene expression analysis in tumor-draining lymph nodes, TOX expression measurement, anti-CD69 + anti-PD-1 combination therapy","journal":"Cancer immunology research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined transcription factor (TOX) link and functional differentiation readout; single lab","pmids":["37216576"],"is_preprint":false},{"year":2018,"finding":"CD69 targeting with anti-CD69 mAb induced rapid and massive mobilization of bone marrow leukocytes and hematopoietic stem and progenitor cells (HSPCs). This mobilization was inhibited by S1P desensitization with FTY720, and was accompanied by increased S1PR1 and CXCR4 expression. mTOR pathway activation (increased p70S6K, S6, 4E-BP1 phosphorylation) was detected after anti-CD69 treatment, and rapamycin inhibited anti-CD69-induced HSPC mobilization.","method":"Anti-CD69 mAb in vivo treatment, flow cytometry of mobilized BM cells, FTY720 and rapamycin pharmacological inhibition, phosphoprotein analysis by Western blot","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo mAb treatment with pharmacological dissection of S1P and mTOR pathways; single lab, multiple inhibitors","pmids":["29483712"],"is_preprint":false},{"year":2009,"finding":"CD69 expressed on CD4 T cells is required for their migration into asthmatic lung, and for Th2 response induction. CD69 deficiency compromised CD4 T cell migration into the asthmatic lung and reduced VCAM-1 expression, suggesting VCAM-1 involvement in CD69-dependent Th2 cell migration.","method":"CD69-/- mouse OVA-induced airway inflammation model, adoptive transfer of antigen-primed CD4 T cells, lung CD4 T cell migration analysis, VCAM-1 expression measurement, anti-CD69 mAb treatment","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO and adoptive transfer with defined migratory phenotype and VCAM-1 expression link; single lab","pmids":["19923457"],"is_preprint":false},{"year":2013,"finding":"CD69 deficiency in CD4 T cells increases expression of chemokines CCL-1, CXCL-10, and CCL-19, and increases expression/affinity of chemokine receptors, resulting in enhanced in vitro migration toward chemokine stimuli. In vivo, CD69-/- CD4 T cells accumulate in greater numbers in intestinal colonic lamina propria during colitis, and neutralization of these chemokines significantly decreased histopathological signs of colitis in CD69-/- mice.","method":"CD69-/- mouse competitive homing assay, DSS-induced colitis and antigen-specific transfer colitis, chemokine/receptor expression analysis, chemokine neutralization in vivo, in vitro migration assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined chemokine mechanism and in vivo rescue; single lab, multiple model systems","pmids":["23776480"],"is_preprint":false},{"year":2013,"finding":"CD69 mRNA expression in monocytes is induced by TGF-β and 1α,25-dihydroxyvitamin D3 as a primary target gene. Upregulation depends on Smad3 (shown by Smad3 knockdown) and on TAK1-mediated p38 MAPK activation. TGF-β and 1α,25(OH)2D3 do not influence CD69 mRNA stability; the effect is specific to monocytes and not observed in T or B cell lines.","method":"qPCR kinetics, mRNA stability assay with transcription inhibitor and 3'UTR reporter, Smad3 functional knockdown, MAPK inhibitor panel, promoter reporter assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic dissection with Smad3 KD and kinase inhibitors, multiple orthogonal methods; single lab","pmids":["23696902"],"is_preprint":false},{"year":2022,"finding":"CD69 expression on Tregs increases survival after myocardial infarction in mice. CD69+ Tregs, by induction of AhR-dependent CD39 ectonucleotidase activity, induced apoptosis and decreased IL-17A production in γδT cells. Adoptive transfer of CD69+ Tregs into Cd69-/- mice after coronary ligation reduced IL-17+ γδT cell recruitment and increased survival.","method":"CD69-/- mouse coronary ligation model, adoptive transfer of CD69+ Tregs, AhR inhibition, CD39 ectonucleotidase activity assay, flow cytometry of γδT cells","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — adoptive transfer with defined AhR/CD39 mechanism, in vivo rescue; single lab","pmids":["36066993"],"is_preprint":false},{"year":1996,"finding":"CD69 ligation induces apoptosis in GM-CSF-cultured eosinophils in a crosslinking-dependent manner, independent of TGF-β1. This apoptosis requires molecular crosslinking and does not correlate with eosinophil peroxidase release.","method":"Anti-CD69 mAb and F(ab)2 fragments applied to GM-CSF-cultured eosinophils, apoptosis measurement by morphology, DNA laddering, and flow cytometry, TGF-β1 neutralization, EPO release assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple apoptosis detection methods, F(ab)2 controls, TGF-β1 neutralization; single lab","pmids":["8639899"],"is_preprint":false},{"year":1996,"finding":"LPS/anti-CD69 co-stimulation-induced monocyte apoptosis involves at least three independent, non-redundant signaling pathways: (i) phospholipase A2 and lipoxygenase-mediated arachidonic acid metabolism, (ii) NO generation, and (iii) pertussis toxin-sensitive (ADP-ribosylation-dependent) G-protein events. Each pathway is necessary but insufficient alone to induce apoptosis.","method":"Inhibitors of PLA2, lipoxygenase, NO synthesis, pertussis toxin (wild-type vs. ADP-ribosylation-deficient mutant), TNF production and NO generation assays","journal":"Cellular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection with multiple pathway inhibitors and mutant toxin controls; single lab","pmids":["8964080"],"is_preprint":false},{"year":1997,"finding":"In murine macrophages, CD69 expression is not constitutive but is induced by IFN-γ plus LPS, TNF-α, or LPS alone, and is inhibited by PGE2 or dibutyryl-cAMP. Anti-CD69 mAb stimulation of macrophages in the presence of IFN-γ induces nitric oxide production and TNF-α release, and triggers elimination of intracellular Leishmania parasites.","method":"Flow cytometry of CD69 expression under various stimuli, pharmacological inhibition (PGE2, cAMP), anti-CD69 mAb stimulation, NO and TNF-α assays, Leishmania elimination assay","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible expression characterized with multiple stimuli and inhibitors, functional signaling readouts; single lab","pmids":["9307073"],"is_preprint":false},{"year":2009,"finding":"The CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal noncoding sequences (CNS1-4). CNS2 and CNS4 function as inducible enhancers in T cells. The CD69 promoter alone supports positive selection-dependent thymic expression but not mature lymphocyte expression. CNS1-4 elements interact both positively (CNS3, CNS4) and negatively (CNS1, CNS2 together) with the promoter to confer developmental-stage and lineage-specific regulation.","method":"DNase I hypersensitivity mapping, chromatin immunoprecipitation for epigenetic modifications, transient transfection reporter assays, transgenic mouse analysis with CNS combinations","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple regulatory elements tested in vivo and in vitro; single lab with multiple approaches","pmids":["19841192"],"is_preprint":false},{"year":2019,"finding":"CD69 deficiency in mice promotes a prothrombotic phenotype with increased plasma VWF content and activity, increased VWF expression in brain vessels, and greater fibrinogen accumulation in ischemic brain tissue after stroke. Ischemia upregulated Cd69 mRNA in brain endothelial cells. This worsening effect was not attributable to lymphocytes or other hematopoietic cells (shown by chimeric mice). Blocking VWF reduced infarct volume and reversed the detrimental effect of CD69 deficiency, indicating CD69 acts as a downregulator of endothelial activation.","method":"CD69-/- and chimeric mice with MCAO stroke model, endothelial cell sorting and mRNA analysis, VWF ELISA and activity assay, fibrin(ogen) immunostaining, VWF-blocking antibody treatment","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific chimeras to attribute endothelial function, VWF rescue experiment, multiple readouts; single lab","pmids":["30582456"],"is_preprint":false}],"current_model":"CD69 is a type II transmembrane C-type lectin homodimer that functions as a signaling receptor and cis-interacting regulator of multiple membrane proteins: it physically associates with and acts as a protein agonist of S1PR1 (via its transmembrane helix contacting S1PR1-TM4, inducing Gi-coupled receptor internalization and degradation to inhibit lymphocyte egress), interacts with the amino acid transporter complex LAT1-CD98 to control L-tryptophan uptake and AhR-dependent IL-22 secretion, and associates via its cytoplasmic tail with the Jak3/Stat5 pathway to limit Th17 differentiation; upon crosslinking, CD69 signals through a Src-Syk-PLCγ2-Vav1 cascade activating ERK, Ca2+ influx, and degranulation in NK cells, and drives IL-2/IFN-γ gene expression and proliferation in T cells; natural extracellular ligands include galectin-1 and the S100A8/S100A9 complex (in a glycosylation-dependent manner), and the molecule additionally regulates endothelial VWF expression, thymocyte/lymphocyte egress from lymphoid organs, and Treg suppressive function through AhR-dependent CD39 ectonucleotidase activity."},"narrative":{"mechanistic_narrative":"CD69 is a type II transmembrane C-type lectin glycoprotein, expressed as a phosphorylated disulfide-linked homodimer, that functions as an early activation antigen and cis-acting regulator of lymphocyte migration and effector programs across multiple leukocyte lineages [PMID:8340758, PMID:2388032]. Its best-defined molecular role is as a cis protein agonist of the egress receptor S1PR1: CD69 physically complexes with S1PR1 (but not S1PR3) through an integral-membrane interaction in which the CD69 transmembrane helix contacts S1PR1-TM4, allosterically activating the receptor, driving Gi-dependent internalization and degradation, and abolishing S1P gradient sensing to retain lymphocytes in lymphoid organs and peripheral tissues [PMID:37039481, PMID:16525420, PMID:20463015, PMID:25624457]. Acting downstream of type I interferon signaling, this CD69–S1PR1 axis governs thymocyte export and tissue-resident memory T cell formation [PMID:16525420, PMID:12039905, PMID:25624457]. Beyond S1PR1, CD69 associates with additional membrane partners to shape T cell fate: it binds the LAT1-CD98 amino acid transporter to control L-tryptophan uptake and AhR-dependent IL-22 secretion, and its cytoplasmic tail engages the Jak3/Stat5 pathway to restrain RORγt-driven Th17 differentiation [PMID:27376471, PMID:20696842]. CD69 recognizes natural extracellular ligands—galectin-1 and the S100A8/S100A9 complex—in a carbohydrate- and glycosylation-dependent manner, linking ligand engagement to Th17 suppression and Treg generation [PMID:24752896, PMID:26296369]. Upon antibody crosslinking CD69 transduces an activating signal through a Src-family/Syk–PLCγ2–Vav1 cascade that activates ERK and Ca2+ influx to drive NK cell degranulation and cytotoxicity, and—together with PKC co-stimulation—IL-2/IFN-γ gene expression and T cell proliferation [PMID:2501389, PMID:12077230, PMID:10671222]. Functionally, CD69 negatively regulates antitumor T cell effector function and exhaustion via TOX, modulates Treg suppression through AhR-dependent CD39, and downregulates endothelial VWF expression to limit thrombosis [PMID:30085193, PMID:37216576, PMID:36066993, PMID:30582456].","teleology":[{"year":1989,"claim":"Established that CD69 is not merely an activation marker but a signaling receptor by showing that its crosslinking transduces a defined activating signal in T cells.","evidence":"Anti-CD69 mAb crosslinking with Ca2+, cytokine gene expression, and proliferation readouts in T cells","pmids":["2501389"],"confidence":"High","gaps":["Did not identify the proximal kinases or adaptors","PKC co-stimulation requirement left the autonomous signaling capacity undefined"]},{"year":1990,"claim":"Defined the physical nature of CD69 as a phosphorylated disulfide-linked homodimer and showed its signaling extends beyond lymphocytes to platelet activation.","evidence":"Biochemical characterization and anti-CD69 crosslinking aggregation/degranulation assays in human platelets","pmids":["2388032"],"confidence":"High","gaps":["No molecular receptor or downstream pathway resolved","Physiological ligand on platelets unknown"]},{"year":1993,"claim":"Provided the foundational molecular identity—cloning revealed CD69 as a type II C-type lectin glycoprotein related to NK receptor families, framing all later structure-function work.","evidence":"cDNA cloning, functional COS-7 expression, chromosomal mapping, homology analysis","pmids":["8340758"],"confidence":"High","gaps":["No natural ligand identified at this stage","Lectin domain glycan specificity unresolved"]},{"year":1994,"claim":"Connected CD69 induction to TCR signaling biochemistry by placing p21ras activation upstream of CD69 surface expression.","evidence":"Constitutively active and dominant-negative Ras constructs with GTP-Ras IP and AP-1 reporter in Jurkat cells","pmids":["7907294"],"confidence":"High","gaps":["Transcription factors directly driving the CD69 promoter not defined here","Relationship of Ras pathway to lineage-specific expression unclear"]},{"year":2002,"claim":"Dissected the CD69 outgoing signaling cascade in NK cells, identifying Src→Syk→PLCγ2/Vav1 as the effector axis for cytotoxicity.","evidence":"Anti-CD69 crosslinking with IP/kinase assays, Src/Syk inhibitors, and cytotoxicity readouts in IL-2-activated NK cells","pmids":["12077230"],"confidence":"High","gaps":["Direct cytoplasmic adaptor linking CD69 to Src/Syk not identified","How the short cytoplasmic tail nucleates kinase recruitment unresolved"]},{"year":2002,"claim":"Demonstrated genetically that CD69 controls thymocyte egress, separating its retention function from any role in maturation or selection.","evidence":"Dose-dependent CD69 transgenic mouse with thymic export quantification and selection/signaling controls","pmids":["12039905"],"confidence":"High","gaps":["Molecular mechanism of retention not yet identified (pre-S1PR1 discovery)"]},{"year":2006,"claim":"Identified the central mechanistic partner—CD69 physically complexes with S1PR1 to downmodulate it, explaining lymphocyte retention downstream of type I IFN.","evidence":"Co-IP, coexpression chemotaxis assays, CD69-/- mice with poly(I:C)/LCMV, CD69-CD3ζ chimera reporter","pmids":["16525420"],"confidence":"High","gaps":["Interface residues and structural basis unknown","Whether interaction is direct or requires accessory proteins unresolved"]},{"year":2010,"claim":"Mapped the CD69–S1PR1 interaction to transmembrane/membrane-proximal domains and S1PR1-TM4, and linked it to S1PR1 degradation and a ligand-bound-like conformation.","evidence":"CD69/NKRp1A domain swaps, S1PR1 mutagenesis, radioligand binding, T cell egress assays","pmids":["20463015"],"confidence":"High","gaps":["Atomic structure of the complex not yet resolved","Mechanism of CD69-induced degradation not defined"]},{"year":2010,"claim":"Revealed a cytoplasmic-tail signaling function: CD69 engages Jak3/Stat5 to restrain Th17 differentiation, broadening its role from migration to T cell fate.","evidence":"Co-IP of CD69 tail with Jak3/Stat5, in vitro Th17 differentiation of CD69-/- cells, Jak3 inhibition, IL-2 rescue, in vivo models","pmids":["20696842"],"confidence":"High","gaps":["Direct binding interface between cytoplasmic tail and Jak3 not mapped","Whether association is constitutive or ligand-induced unclear"]},{"year":2014,"claim":"Identified galectin-1 as a bona fide carbohydrate-dependent ligand of CD69, providing a physiological trigger for its Th17-suppressive function.","evidence":"CD69-ECD pulldown + MS, surface plasmon resonance, blocking antibodies, Th17 assays","pmids":["24752896"],"confidence":"High","gaps":["Downstream signaling triggered by galectin-1 engagement not dissected","Affinity in physiological membrane context uncertain"]},{"year":2015,"claim":"Identified the S100A8/S100A9 complex as a second natural ligand and showed CD69 N-glycan sialylation gates ligand-driven Treg generation via SOCS3/STAT3.","evidence":"IP-MS, in vitro binding/competition, glycomics, CD69 RNAi, STAT3 signaling readouts in human PBMCs","pmids":["26296369"],"confidence":"Medium","gaps":["Single-lab findings without independent replication","How glycan editing is regulated in vivo unknown"]},{"year":2015,"claim":"Tied CD69 surface expression to tissue-resident memory formation by linking it to S1PR1 transcriptional downregulation and prolonged peripheral retention.","evidence":"Flow/gene expression of skin CD8 T cells, CD69-/- mice, type I IFNR manipulation, retention/memory assays","pmids":["25624457"],"confidence":"High","gaps":["Mechanism coupling CD69 to S1PR1 transcriptional repression not defined","Generality across non-skin tissues not addressed"]},{"year":2016,"claim":"Discovered a metabolic regulatory function: CD69 associates with LAT1-CD98 to control tryptophan uptake and AhR-dependent IL-22, linking it to psoriasis.","evidence":"Co-IP, transporter surface flow cytometry, metabolite measurement, CD69-/- psoriasis model with in vivo rescue","pmids":["27376471"],"confidence":"High","gaps":["Stoichiometry and structural basis of the CD69–LAT1-CD98 interaction unknown","Whether the same complex operates in other T cell subsets unclear"]},{"year":2023,"claim":"Provided the atomic mechanism: cryo-EM showed CD69-TM contacts S1PR1-TM4 to allosterically activate the receptor and engage Gi, establishing CD69 as a cis protein agonist.","evidence":"Cryo-EM of CD69–S1PR1–Gi, interface mutagenesis, receptor internalization assays","pmids":["37039481"],"confidence":"High","gaps":["Structure does not capture the degradation/trafficking step","How CD69 dimer asymmetry is regulated in cells unresolved"]},{"year":2023,"claim":"Connected CD69 to tumor T cell differentiation by showing it controls TOX expression, defining a checkpoint-combinable target.","evidence":"CD69-/- tumor model, TOX expression analysis in tumor-draining lymph nodes, anti-CD69 + anti-PD-1 therapy","pmids":["37216576"],"confidence":"Medium","gaps":["Single-lab study without independent replication","Molecular link between CD69 signaling and TOX transcription not defined"]},{"year":null,"claim":"How CD69's multiple cis membrane interactions (S1PR1, LAT1-CD98), its glycan-dependent ligand engagements, and its cytoplasmic Jak3/Stat5 coupling are integrated and switched within a single cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of how one CD69 dimer partitions among distinct partner complexes","Cytoplasmic tail adaptor(s) coupling CD69 to Src/Syk and Jak3 not biochemically identified","Quantitative rules governing glycosylation-dependent ligand selectivity unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[7,9,10]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,2]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,8,11]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[15]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,7,9]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,4,13,17]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[1,2,17]}],"complexes":[],"partners":["S1PR1","SLC7A5","SLC3A2","JAK3","STAT5","LGALS1","S100A8","S100A9"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q07108","full_name":"Early activation antigen CD69","aliases":["Activation inducer molecule","AIM","BL-AC/P26","C-type lectin domain family 2 member C","EA1","Early T-cell activation antigen p60","GP32/28","Leukocyte surface antigen Leu-23","MLR-3"],"length_aa":199,"mass_kda":22.6,"function":"Transmembrane protein expressed mainly on T-cells resident in mucosa that plays an essential role in immune cell homeostasis. Rapidly expressed on the surface of platelets, T-lymphocytes and NK cells upon activation by various stimuli, such as antigen recognition or cytokine signaling, stimulates different signaling pathways in different cell types (PubMed:24752896, PubMed:26296369, PubMed:35930205). Negatively regulates Th17 cell differentiation through its carbohydrate dependent interaction with galectin-1/LGALS1 present on immature dendritic cells (PubMed:24752896). Association of CD69 cytoplasmic tail with the JAK3/STAT5 signaling pathway regulates the transcription of RORgamma/RORC and, consequently, differentiation toward the Th17 lineage (By similarity). Also acts via the S100A8/S100A9 complex present on peripheral blood mononuclear cells to promote the conversion of naive CD4 T-cells into regulatory T-cells (PubMed:26296369). Acts as an oxidized low-density lipoprotein (oxLDL) receptor in CD4 T-lymphocytes and negatively regulates the inflammatory response by inducing the expression of PDCD1 through the activation of NFAT (PubMed:35930205). Participates in adipose tissue-derived mesenchymal stem cells (ASCs)-mediated protection against P.aeruginosa infection. Mechanistically, specifically recognizes P.aeruginosa to promote ERK1 activation, followed by granulocyte-macrophage colony-stimulating factor (GM-CSF) and other inflammatory cytokines secretion (PubMed:34841721). In eosinophils, induces IL-10 production through the ERK1/2 pathway (By similarity). Negatively regulates the chemotactic responses of effector lymphocytes and dendritic cells (DCs) to sphingosine 1 phosphate/S1P by acting as a S1PR1 receptor agonist and facilitating the internalization and degradation of the receptor (PubMed:37039481)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q07108/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD69","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD69","total_profiled":1310},"omim":[{"mim_id":"619374","title":"IMMUNODEFICIENCY 81; IMD81","url":"https://www.omim.org/entry/619374"},{"mim_id":"618307","title":"IMMUNODEFICIENCY 129; IMD129","url":"https://www.omim.org/entry/618307"},{"mim_id":"618306","title":"PROLINE-RICH PROTEIN 7; PRR7","url":"https://www.omim.org/entry/618306"},{"mim_id":"617514","title":"IMMUNODEFICIENCY 52; IMD52","url":"https://www.omim.org/entry/617514"},{"mim_id":"612087","title":"C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER A; CLEC2A","url":"https://www.omim.org/entry/612087"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":159.6},{"tissue":"lymphoid tissue","ntpm":88.3}],"url":"https://www.proteinatlas.org/search/CD69"},"hgnc":{"alias_symbol":["CLEC2C"],"prev_symbol":[]},"alphafold":{"accession":"Q07108","domains":[{"cath_id":"3.10.100.10","chopping":"89-196","consensus_level":"high","plddt":98.0181,"start":89,"end":196}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07108","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q07108-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q07108-F1-predicted_aligned_error_v6.png","plddt_mean":82.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD69","jax_strain_url":"https://www.jax.org/strain/search?query=CD69"},"sequence":{"accession":"Q07108","fasta_url":"https://rest.uniprot.org/uniprotkb/Q07108.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q07108/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07108"}},"corpus_meta":[{"pmid":"16525420","id":"PMC_16525420","title":"CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.","date":"2006","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16525420","citation_count":983,"is_preprint":false},{"pmid":"28475283","id":"PMC_28475283","title":"CD69: from activation marker to metabolic gatekeeper.","date":"2017","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28475283","citation_count":747,"is_preprint":false},{"pmid":"7804122","id":"PMC_7804122","title":"The activation antigen CD69.","date":"1994","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/7804122","citation_count":453,"is_preprint":false},{"pmid":"25624457","id":"PMC_25624457","title":"Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25624457","citation_count":434,"is_preprint":false},{"pmid":"7945773","id":"PMC_7945773","title":"The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells.","date":"1994","source":"Immunology today","url":"https://pubmed.ncbi.nlm.nih.gov/7945773","citation_count":396,"is_preprint":false},{"pmid":"2501389","id":"PMC_2501389","title":"T cell activation via Leu-23 (CD69).","date":"1989","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2501389","citation_count":266,"is_preprint":false},{"pmid":"8340758","id":"PMC_8340758","title":"Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors.","date":"1993","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8340758","citation_count":263,"is_preprint":false},{"pmid":"20463015","id":"PMC_20463015","title":"CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20463015","citation_count":254,"is_preprint":false},{"pmid":"8095460","id":"PMC_8095460","title":"CD69 expression during selection and maturation of CD4+8+ thymocytes.","date":"1993","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8095460","citation_count":251,"is_preprint":false},{"pmid":"7902130","id":"PMC_7902130","title":"CD69 cell surface expression identifies developing thymocytes which audition for T cell antigen receptor-mediated positive selection.","date":"1993","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7902130","citation_count":206,"is_preprint":false},{"pmid":"10466080","id":"PMC_10466080","title":"CD69 and regulation of the immune function.","date":"1999","source":"Immunopharmacology and immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/10466080","citation_count":188,"is_preprint":false},{"pmid":"10515800","id":"PMC_10515800","title":"Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever.","date":"1999","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10515800","citation_count":161,"is_preprint":false},{"pmid":"23954168","id":"PMC_23954168","title":"Is CD69 an effective brake to control inflammatory diseases?","date":"2013","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23954168","citation_count":153,"is_preprint":false},{"pmid":"7907294","id":"PMC_7907294","title":"Involvement of p21ras activation in T cell CD69 expression.","date":"1994","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7907294","citation_count":127,"is_preprint":false},{"pmid":"12039905","id":"PMC_12039905","title":"A potential role for CD69 in thymocyte emigration.","date":"2002","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12039905","citation_count":125,"is_preprint":false},{"pmid":"8301128","id":"PMC_8301128","title":"The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8301128","citation_count":115,"is_preprint":false},{"pmid":"20696842","id":"PMC_20696842","title":"CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20696842","citation_count":111,"is_preprint":false},{"pmid":"8020549","id":"PMC_8020549","title":"Regulation of RAG-1 and CD69 expression in the thymus during positive and negative selection.","date":"1994","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8020549","citation_count":105,"is_preprint":false},{"pmid":"2388032","id":"PMC_2388032","title":"CD69 is expressed on platelets and mediates platelet activation and aggregation.","date":"1990","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2388032","citation_count":104,"is_preprint":false},{"pmid":"27376471","id":"PMC_27376471","title":"CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27376471","citation_count":101,"is_preprint":false},{"pmid":"30185773","id":"PMC_30185773","title":"CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30185773","citation_count":94,"is_preprint":false},{"pmid":"10733501","id":"PMC_10733501","title":"Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10733501","citation_count":88,"is_preprint":false},{"pmid":"24752896","id":"PMC_24752896","title":"The leukocyte activation receptor CD69 controls T cell differentiation through its interaction with galectin-1.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24752896","citation_count":84,"is_preprint":false},{"pmid":"9448032","id":"PMC_9448032","title":"Temporal dynamics of CD69 expression on lymphoid cells.","date":"1997","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/9448032","citation_count":83,"is_preprint":false},{"pmid":"9618391","id":"PMC_9618391","title":"CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils.","date":"1998","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9618391","citation_count":81,"is_preprint":false},{"pmid":"24934597","id":"PMC_24934597","title":"Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression.","date":"2014","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/24934597","citation_count":80,"is_preprint":false},{"pmid":"27226093","id":"PMC_27226093","title":"Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27226093","citation_count":79,"is_preprint":false},{"pmid":"30085193","id":"PMC_30085193","title":"Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells.","date":"2018","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30085193","citation_count":78,"is_preprint":false},{"pmid":"8639899","id":"PMC_8639899","title":"Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8639899","citation_count":72,"is_preprint":false},{"pmid":"19923457","id":"PMC_19923457","title":"CD69 controls the pathogenesis of allergic airway inflammation.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19923457","citation_count":70,"is_preprint":false},{"pmid":"26296369","id":"PMC_26296369","title":"Glycosylation-dependent interaction between CD69 and S100A8/S100A9 complex is required for regulatory T-cell differentiation.","date":"2015","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/26296369","citation_count":66,"is_preprint":false},{"pmid":"33554350","id":"PMC_33554350","title":"The Clinical Significance of Hepatic CD69+ CD103+ CD8+ Resident-Memory T Cells in Autoimmune Hepatitis.","date":"2021","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/33554350","citation_count":65,"is_preprint":false},{"pmid":"1586955","id":"PMC_1586955","title":"CD69 molecule in human neutrophils: its expression and role in signal-transducing mechanisms.","date":"1992","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1586955","citation_count":64,"is_preprint":false},{"pmid":"20621339","id":"PMC_20621339","title":"The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity.","date":"2010","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20621339","citation_count":64,"is_preprint":false},{"pmid":"10671222","id":"PMC_10671222","title":"CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10671222","citation_count":59,"is_preprint":false},{"pmid":"30687011","id":"PMC_30687011","title":"Expression of Tmem119/Sall1 and Ccr2/CD69 in FACS-Sorted Microglia- and Monocyte/Macrophage-Enriched Cell Populations After Intracerebral Hemorrhage.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30687011","citation_count":58,"is_preprint":false},{"pmid":"11994706","id":"PMC_11994706","title":"Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3.","date":"2002","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11994706","citation_count":55,"is_preprint":false},{"pmid":"15692061","id":"PMC_15692061","title":"Induction of tumor NK-cell immunity by anti-CD69 antibody therapy.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15692061","citation_count":53,"is_preprint":false},{"pmid":"23776480","id":"PMC_23776480","title":"The early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestine.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23776480","citation_count":52,"is_preprint":false},{"pmid":"21427408","id":"PMC_21427408","title":"CD69: an unexpected regulator of TH17 cell-driven inflammatory responses.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21427408","citation_count":49,"is_preprint":false},{"pmid":"16342326","id":"PMC_16342326","title":"CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16342326","citation_count":47,"is_preprint":false},{"pmid":"9307073","id":"PMC_9307073","title":"Expression and function of the early activation antigen CD69 in murine macrophages.","date":"1997","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/9307073","citation_count":46,"is_preprint":false},{"pmid":"19841192","id":"PMC_19841192","title":"CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal elements.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19841192","citation_count":46,"is_preprint":false},{"pmid":"36066993","id":"PMC_36066993","title":"CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/36066993","citation_count":45,"is_preprint":false},{"pmid":"1612643","id":"PMC_1612643","title":"Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.","date":"1992","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/1612643","citation_count":44,"is_preprint":false},{"pmid":"17453964","id":"PMC_17453964","title":"CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery.","date":"2007","source":"Cytotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/17453964","citation_count":44,"is_preprint":false},{"pmid":"30941121","id":"PMC_30941121","title":"Adipose Tissue in Persons With HIV Is Enriched for CD4+ T Effector Memory and T Effector Memory RA+ Cells, Which Show Higher CD69 Expression and CD57, CX3CR1, GPR56 Co-expression With Increasing Glucose Intolerance.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30941121","citation_count":43,"is_preprint":false},{"pmid":"7538976","id":"PMC_7538976","title":"CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.","date":"1995","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7538976","citation_count":41,"is_preprint":false},{"pmid":"9116719","id":"PMC_9116719","title":"Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.","date":"1997","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/9116719","citation_count":40,"is_preprint":false},{"pmid":"31928947","id":"PMC_31928947","title":"Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings.","date":"2020","source":"Allergology international : official journal of the Japanese Society of Allergology","url":"https://pubmed.ncbi.nlm.nih.gov/31928947","citation_count":39,"is_preprint":false},{"pmid":"11034393","id":"PMC_11034393","title":"Functional analysis of ligand-binding and signal transduction domains of CD69 and CD23 C-type lectin leukocyte receptors.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11034393","citation_count":37,"is_preprint":false},{"pmid":"33548061","id":"PMC_33548061","title":"Implication of CD69+ CD103+ tissue-resident-like CD8+ T cells as a potential immunotherapeutic target for cholangiocarcinoma.","date":"2021","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/33548061","citation_count":36,"is_preprint":false},{"pmid":"23373457","id":"PMC_23373457","title":"Dendritic cell activation, phagocytosis and CD69 expression on cognate T cells are suppressed by n-3 long-chain polyunsaturated fatty acids.","date":"2013","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23373457","citation_count":36,"is_preprint":false},{"pmid":"12077230","id":"PMC_12077230","title":"Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12077230","citation_count":35,"is_preprint":false},{"pmid":"35689672","id":"PMC_35689672","title":"The cellular and molecular basis of CD69 function in anti-tumor immunity.","date":"2022","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35689672","citation_count":33,"is_preprint":false},{"pmid":"27151919","id":"PMC_27151919","title":"Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis.","date":"2016","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/27151919","citation_count":32,"is_preprint":false},{"pmid":"18046548","id":"PMC_18046548","title":"CLEC2A: a novel, alternatively spliced and skin-associated member of the NKC-encoded AICL-CD69-LLT1 family.","date":"2007","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/18046548","citation_count":32,"is_preprint":false},{"pmid":"10445598","id":"PMC_10445598","title":"CD69 surface expression on human lung eosinophils after segmental allergen provocation.","date":"1999","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/10445598","citation_count":32,"is_preprint":false},{"pmid":"24668348","id":"PMC_24668348","title":"Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1.","date":"2014","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/24668348","citation_count":32,"is_preprint":false},{"pmid":"23658623","id":"PMC_23658623","title":"Curcumin inhibits CD4(+) T cell activation, but augments CD69 expression and TGF-β1-mediated generation of regulatory T cells at late phase.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23658623","citation_count":32,"is_preprint":false},{"pmid":"37892710","id":"PMC_37892710","title":"The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis.","date":"2023","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37892710","citation_count":31,"is_preprint":false},{"pmid":"7783055","id":"PMC_7783055","title":"Characterization and regulation of CD69 expression on rheumatoid arthritis synovial fluid T cells.","date":"1995","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/7783055","citation_count":31,"is_preprint":false},{"pmid":"17505822","id":"PMC_17505822","title":"Chicken CD69 and CD94/NKG2-like genes in a chromosomal region syntenic to mammalian natural killer gene complex.","date":"2007","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17505822","citation_count":31,"is_preprint":false},{"pmid":"37039481","id":"PMC_37039481","title":"Transmembrane protein CD69 acts as an S1PR1 agonist.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37039481","citation_count":30,"is_preprint":false},{"pmid":"36720287","id":"PMC_36720287","title":"Lung-resident CD69+ST2+ TH2 cells mediate long-term type 2 memory to inhaled antigen in mice.","date":"2023","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36720287","citation_count":29,"is_preprint":false},{"pmid":"30262053","id":"PMC_30262053","title":"Combined CD25, CD64, and CD69 biomarker panel for flow cytometry diagnosis of sepsis.","date":"2018","source":"Talanta","url":"https://pubmed.ncbi.nlm.nih.gov/30262053","citation_count":29,"is_preprint":false},{"pmid":"37056775","id":"PMC_37056775","title":"The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37056775","citation_count":28,"is_preprint":false},{"pmid":"32528679","id":"PMC_32528679","title":"Synovial fluid CD69+CD8+ T cells with tissue-resident phenotype mediate perforin-dependent citrullination in rheumatoid arthritis.","date":"2020","source":"Clinical & translational immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32528679","citation_count":28,"is_preprint":false},{"pmid":"35862229","id":"PMC_35862229","title":"Using CD69 PET Imaging to Monitor Immunotherapy-Induced Immune Activation.","date":"2022","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/35862229","citation_count":27,"is_preprint":false},{"pmid":"33462898","id":"PMC_33462898","title":"CD4+ and CD8+ T cells in sentinel nodes exhibit distinct pattern of PD-1, CD69, and HLA-DR expression compared to tumor tissue in oral squamous cell carcinoma.","date":"2021","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/33462898","citation_count":27,"is_preprint":false},{"pmid":"36045683","id":"PMC_36045683","title":"CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36045683","citation_count":24,"is_preprint":false},{"pmid":"31340848","id":"PMC_31340848","title":"CD4+CD69+ T cells and CD4+CD25+FoxP3+ Treg cells imbalance in peripheral blood, spleen and peritoneal lavage from pristane-induced systemic lupus erythematosus (SLE) mice.","date":"2019","source":"Advances in rheumatology (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31340848","citation_count":24,"is_preprint":false},{"pmid":"29799723","id":"PMC_29799723","title":"Multiparameter Affinity Microchip for Early Sepsis Diagnosis Based on CD64 and CD69 Expression and Cell Capture.","date":"2018","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29799723","citation_count":24,"is_preprint":false},{"pmid":"32986791","id":"PMC_32986791","title":"Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients.","date":"2020","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/32986791","citation_count":23,"is_preprint":false},{"pmid":"39694701","id":"PMC_39694701","title":"Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8+CD69+ T cells.","date":"2024","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39694701","citation_count":22,"is_preprint":false},{"pmid":"32849474","id":"PMC_32849474","title":"Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters.","date":"2020","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32849474","citation_count":22,"is_preprint":false},{"pmid":"30582456","id":"PMC_30582456","title":"CD69 Plays a Beneficial Role in Ischemic Stroke by Dampening Endothelial Activation.","date":"2019","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/30582456","citation_count":22,"is_preprint":false},{"pmid":"37223078","id":"PMC_37223078","title":"Unraveling CD69 signaling pathways, ligands and laterally associated molecules.","date":"2023","source":"EXCLI journal","url":"https://pubmed.ncbi.nlm.nih.gov/37223078","citation_count":21,"is_preprint":false},{"pmid":"29483712","id":"PMC_29483712","title":"Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR.","date":"2018","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/29483712","citation_count":21,"is_preprint":false},{"pmid":"23119065","id":"PMC_23119065","title":"CD69 does not affect the extent of T cell priming.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23119065","citation_count":21,"is_preprint":false},{"pmid":"8964080","id":"PMC_8964080","title":"CD69-induced monocyte apoptosis involves multiple nonredundant signaling pathways.","date":"1996","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8964080","citation_count":21,"is_preprint":false},{"pmid":"12818356","id":"PMC_12818356","title":"CD69 expression induced by thapsigargin, phorbol ester and ouabain on thymocytes is dependent on external Ca2+ entry.","date":"2003","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12818356","citation_count":21,"is_preprint":false},{"pmid":"11958434","id":"PMC_11958434","title":"CD69 expression on lymphocytes and interleukin-15 levels in synovial fluids from different inflammatory arthropathies.","date":"2002","source":"Rheumatology international","url":"https://pubmed.ncbi.nlm.nih.gov/11958434","citation_count":20,"is_preprint":false},{"pmid":"26701728","id":"PMC_26701728","title":"CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26701728","citation_count":19,"is_preprint":false},{"pmid":"11979374","id":"PMC_11979374","title":"CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas.","date":"2002","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11979374","citation_count":19,"is_preprint":false},{"pmid":"38768914","id":"PMC_38768914","title":"Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38768914","citation_count":19,"is_preprint":false},{"pmid":"34580321","id":"PMC_34580321","title":"Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34580321","citation_count":18,"is_preprint":false},{"pmid":"11145721","id":"PMC_11145721","title":"Anti-CD69 autoantibodies cross-react with low density lipoprotein receptor-related protein 2 in systemic autoimmune diseases.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11145721","citation_count":18,"is_preprint":false},{"pmid":"16284445","id":"PMC_16284445","title":"Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin.","date":"2005","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/16284445","citation_count":18,"is_preprint":false},{"pmid":"27328704","id":"PMC_27328704","title":"Distinct recirculation potential of CD69+CD103- and CD103+ thymic memory CD8+ T cells.","date":"2016","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27328704","citation_count":17,"is_preprint":false},{"pmid":"24975965","id":"PMC_24975965","title":"Increase of CD69, CD161 and CD94 on NK cells in women with recurrent spontaneous abortion and in vitro fertilization failure.","date":"2014","source":"Iranian journal of immunology : IJI","url":"https://pubmed.ncbi.nlm.nih.gov/24975965","citation_count":17,"is_preprint":false},{"pmid":"37216576","id":"PMC_37216576","title":"CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes.","date":"2023","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/37216576","citation_count":16,"is_preprint":false},{"pmid":"37426447","id":"PMC_37426447","title":"Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma.","date":"2023","source":"Cancer research communications","url":"https://pubmed.ncbi.nlm.nih.gov/37426447","citation_count":16,"is_preprint":false},{"pmid":"32890312","id":"PMC_32890312","title":"Evaluating the Timeliness and Specificity of CD69, CD64, and CD25 as Biomarkers of Sepsis in Mice.","date":"2021","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/32890312","citation_count":16,"is_preprint":false},{"pmid":"22544938","id":"PMC_22544938","title":"Differential effect of CD69 targeting on bystander and antigen-specific T cell proliferation.","date":"2012","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/22544938","citation_count":16,"is_preprint":false},{"pmid":"23696902","id":"PMC_23696902","title":"CD69 is a TGF-β/1α,25-dihydroxyvitamin D3 target gene in monocytes.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23696902","citation_count":16,"is_preprint":false},{"pmid":"15144128","id":"PMC_15144128","title":"CD69 expression on neutrophils from patients with rheumatoid arthritis.","date":"2004","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/15144128","citation_count":16,"is_preprint":false},{"pmid":"12797521","id":"PMC_12797521","title":"Intracellular expression of CD69 in endometrial and peripheral T cells represents a useful marker in women with recurrent miscarriage: modulation after allogeneic leukocyte immunotherapy.","date":"2003","source":"American journal of reproductive immunology (New York, N.Y. : 1989)","url":"https://pubmed.ncbi.nlm.nih.gov/12797521","citation_count":16,"is_preprint":false},{"pmid":"16983725","id":"PMC_16983725","title":"The role of CD69 in acute neutrophil-mediated inflammation.","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16983725","citation_count":16,"is_preprint":false},{"pmid":"27595267","id":"PMC_27595267","title":"Increased CD69 Expression on Peripheral Eosinophils from Patients with Food Protein-Induced Enterocolitis Syndrome.","date":"2016","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27595267","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51170,"output_tokens":8541,"usd":0.140813,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18525,"output_tokens":4705,"usd":0.105125,"stage2_stop_reason":"end_turn"},"total_usd":0.245938,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structure of CD69-bound S1PR1 coupled to heterotrimeric Gi complex revealed that the transmembrane helix (TM) of one protomer of the CD69 homodimer contacts S1PR1-TM4, allosterically inducing movement of S1PR1-TMs 5-6 to directly activate the receptor and engage Gi. Mutations at the interface reduced CD69-S1PR1 interactions and receptor internalization. CD69 thus acts in cis as a protein agonist of S1PR1, promoting Gi-dependent S1PR1 internalization, loss of S1P gradient sensing, and inhibition of lymphocyte egress.\",\n      \"method\": \"Cryo-EM structure determination, mutagenesis of interface residues, receptor internalization assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure with mutagenesis validation and functional receptor internalization assays in a single rigorous study\",\n      \"pmids\": [\"37039481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CD69 forms a physical complex with S1PR1 (but not the related receptor S1PR3), inhibits S1PR1 chemotactic function, and leads to downmodulation of S1PR1 surface expression. This mechanism operates downstream of IFN-α/β signaling to promote lymphocyte retention in lymphoid organs. CD69-/- cells retained S1PR1 function after IFN-α/β exposure, and S1PR1 crosslinking co-activated a CD69-CD3ζ chimera.\",\n      \"method\": \"Co-immunoprecipitation, coexpression chemotaxis assays, CD69-/- mouse model with poly(I:C) and LCMV infection, reporter assay with CD69-CD3ζ chimera\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, functional coexpression assays, genetic KO with defined egress phenotype, replicated across multiple stimuli\",\n      \"pmids\": [\"16525420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CD69 suppresses S1PR1 function through an integral membrane interaction requiring the transmembrane and membrane-proximal domains of CD69 and transmembrane helix 4 of S1PR1. N-linked glycosylation, tyrosine sulfation, and desensitization motifs of S1PR1 are not required. CD69 expression leads to reduction of S1PR1 in cell lysates (likely degradation), and the S1PR1-CD69 complex exhibits a longer S1P binding half-life than S1PR1 alone, suggesting CD69 induces a ligand-bound-like S1PR1 conformation that facilitates internalization. A non-S1PR1-binding CD69 mutant failed to inhibit T cell egress.\",\n      \"method\": \"Domain-swapping between CD69 and NKRp1A, S1PR1 mutagenesis, radioligand binding assays, T cell egress assays with CD69 mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with domain-swap and mutagenesis of both proteins, multiple orthogonal methods, functional egress validation\",\n      \"pmids\": [\"20463015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CD69 associates with the aromatic-amino-acid transporter complex LAT1-CD98 (SLC7A5-SLC3A2), regulating its surface expression and uptake of L-tryptophan. This controls intracellular L-Trp-derived AhR activators, thereby governing AhR-dependent IL-22 secretion by γδ T cells and contributing to psoriasis pathogenesis. In vivo administration of L-Trp, an AhR inhibitor, or IL-22 neutralization abrogated differences between CD69-deficient and wild-type mice in skin inflammation.\",\n      \"method\": \"Co-immunoprecipitation of CD69 with LAT1-CD98, flow cytometry of transporter surface expression, metabolite measurement, CD69-/- mouse model with IL-23-induced psoriasis, in vivo rescue experiments\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP identification of complex, functional KO rescue with multiple orthogonal in vivo and in vitro approaches\",\n      \"pmids\": [\"27376471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CD69 limits Th17 cell differentiation through association of its cytoplasmic tail with the Jak3/Stat5 signaling pathway. CD69 deficiency in CD4+ T cells leads to enhanced RORγt transcription and IL-17 production. Selective Jak3 inhibition enhanced RORγt transcription, and exogenous IL-2 restored Stat5 phosphorylation and inhibited the enhanced Th17 differentiation in CD69-deficient cells.\",\n      \"method\": \"Biochemical co-association of CD69 cytoplasmic tail with Jak3/Stat5 (immunoprecipitation), in vitro Th17 differentiation of CD69-/- T cells, Jak3 inhibition, IL-2 rescue experiments, in vivo OVA-specific TCR transgenic and collagen immunization models\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of CD69 cytoplasmic tail with Jak3/Stat5, pharmacological dissection, and in vivo genetic model, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"20696842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Galectin-1 was identified as a natural ligand for CD69 on dendritic cells. The interaction is direct, specific, and carbohydrate-dependent, as shown by surface plasmon resonance and anti-CD69 blocking. CD69-galectin-1 interaction mediates the negative effect of galectin-1 on Th17 cell differentiation in both human and mouse T cells.\",\n      \"method\": \"Pulldown with CD69-extracellular domain fusion protein followed by mass spectrometry, surface plasmon resonance, blocking antibodies, Th17 differentiation functional assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — pulldown + MS identification, SPR affinity measurement, carbohydrate-dependent blocking, functional Th17 assays; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"24752896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The S100A8/S100A9 complex was identified as a natural ligand for CD69 in human PBMCs. The interaction is glycosylation-dependent: removal of N-linked glycans from CD69 (peptide-N-glycosidase treatment) abolished the association, and removal of sialic acid from CD69 N-glycans reversed Treg cell generation. CD69-S100A8/S100A9 interaction upregulates SOCS3, inhibiting STAT3 signaling and supporting TGF-β secretion, thereby promoting Treg differentiation.\",\n      \"method\": \"Immunoprecipitation and mass spectrometry, in vitro binding and competition assay, glycomics analysis of CD69, CD69 RNAi knockdown, STAT3 signaling measurement\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — IP-MS identification, in vitro binding confirmation, glycomics, and functional knockdown; single lab\",\n      \"pmids\": [\"26296369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Cross-linking of CD69 by monoclonal antibody induces prolonged elevation of intracellular Ca2+ primarily through extracellular Ca2+ influx. When combined with PKC activation (by PMA), CD69 stimulation induces IL-2 and IFN-γ gene expression, CD25 upregulation, and IL-2-dependent T cell proliferation. CD69-mediated Ca2+ signal alone cannot activate PKC and cannot trigger cytotoxicity programs.\",\n      \"method\": \"Anti-CD69 mAb crosslinking, intracellular Ca2+ measurement, cytokine gene expression assay, proliferation assay, cyclosporin A inhibition\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct crosslinking with multiple functional readouts (Ca2+ flux, cytokine expression, proliferation), pharmacological dissection, replicated across T cell subsets\",\n      \"pmids\": [\"2501389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"CD69 is constitutively expressed on human platelets as a phosphorylated disulfide-linked homodimer. Anti-CD69 mAb crosslinking induces platelet aggregation in a dose-dependent manner, associated with Ca2+ influx, platelet degranulation (ATP release), and production of thromboxane B2 and PGE2, indicating activation of arachidonic acid metabolism via cyclooxygenase.\",\n      \"method\": \"Flow cytometry and biochemical characterization of platelet CD69, anti-CD69 mAb crosslinking aggregation assay, Ca2+ influx measurement, ATP release assay, thromboxane/prostaglandin ELISA\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct crosslinking with multiple orthogonal functional readouts; single lab but rigorous biochemical characterization\",\n      \"pmids\": [\"2388032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CD69 engagement in IL-2-activated human NK cells leads to rapid and selective activation of the tyrosine kinase Syk (but not ZAP70). Src family kinases (including Lck) are required upstream of Syk activation. Syk and Src kinases control CD69-triggered tyrosine phosphorylation and activation of PLCγ2 and the Rho-family GEF Vav1, which are responsible for CD69-triggered NK cell cytotoxicity.\",\n      \"method\": \"Anti-CD69 mAb crosslinking in IL-2-activated NK cells and RBL transfectants, immunoprecipitation and kinase activity assays, Src/Syk inhibitors, cytotoxicity assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical dissection with IP/kinase assays, pharmacological inhibitors, and functional cytotoxicity readout; multiple orthogonal methods in single lab\",\n      \"pmids\": [\"12077230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD69 engagement activates extracellular signal-regulated kinases (ERK/MAPK), and this ERK activation is required for CD69-mediated cell degranulation. Co-engagement of the CD94/NKG2-A inhibitory receptor suppresses CD69-triggered ERK activation and thereby inhibits CD69-mediated degranulation in RBL transfectants and NK cell cytotoxicity.\",\n      \"method\": \"RBL transfectants expressing CD69 ± CD94/NKG2-A, ERK activation assay, degranulation assay, NK cytotoxicity assay with inhibitory receptor co-crosslinking\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ERK activation linked to function, inhibitory receptor interference demonstrated, single lab with multiple readouts\",\n      \"pmids\": [\"10671222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CD69 cDNA encodes a 199-amino-acid type II membrane glycoprotein with extracellular C-type lectin domain, transmembrane, and intracellular domains. Transient expression of the CD69 cDNA in COS-7 cells recapitulated native CD69 properties. The gene maps to chromosome 12p13-p12 and is a member of the Ca2+-dependent (C-type) lectin superfamily, structurally related to NKG2, NKR-P1, and Ly49 family NK receptors.\",\n      \"method\": \"PCR-based cDNA cloning from peptide sequences, transient expression in COS-7 cells, somatic cell hybrid DNA analysis, fluorescence in situ hybridization, protein sequence homology analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct cDNA cloning with functional expression validation and chromosomal mapping; foundational structural characterization replicated across subsequent studies\",\n      \"pmids\": [\"8340758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Constitutively active v-Ha-ras induced CD69 surface expression in Jurkat T cells, and a dominant-negative c-Ha-ras-N17 mutant markedly reduced TCR/CD3-mediated CD69 induction, demonstrating a central role for p21ras activation in TCR/CD3-mediated CD69 expression.\",\n      \"method\": \"Transfection of constitutively active and dominant-negative Ras constructs in Jurkat cells, GTP-bound Ras immunoprecipitation, AP-1-CAT reporter assay, flow cytometry of CD69 expression\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function Ras constructs with mechanistic readouts (GTP-Ras IP, AP-1 reporter, CD69 surface expression); single lab, multiple orthogonal methods\",\n      \"pmids\": [\"7907294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Constitutive surface expression of CD69 in transgenic mice caused accumulation of phenotypically and functionally mature thymocytes in the thymic medulla with failure of export to the periphery, correlating with transgene dose and CD69 surface levels. CD69 did not affect T cell maturation, TCR signaling, or thymocyte selection, indicating a specific role in controlling thymocyte egress from the thymus.\",\n      \"method\": \"CD69 transgenic mouse generation and characterization, flow cytometry of thymic subsets, functional assays for TCR signaling and selection, thymic export quantification\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic gain-of-function with dose-dependent phenotype, negative controls for selection and signaling, well-defined cellular readout\",\n      \"pmids\": [\"12039905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD69-/- mice showed largely normal T cell development, selection, NK and CTL cytotoxic activity, but B cell development was affected: the B220hi IgMneg bone marrow pre-B cell compartment was augmented, and CD69 deficiency led to slightly increased IgG2a and IgM responses to immunization.\",\n      \"method\": \"Gene-targeted CD69-/- mice, flow cytometry of hematopoietic subsets, TCR transgenic selection model, NK and CTL cytotoxicity assays, immunization and antibody measurement\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — comprehensive KO characterization with multiple cell lineages and functional assays across multiple independent experiments\",\n      \"pmids\": [\"10733501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"In neutrophils, CD69 molecules are stored intracellularly (likely in a trans-Golgi structure, based on brefeldin A insensitivity) and are rapidly mobilized to the cell surface upon activation by PMA or fMLP independently of new protein synthesis. CD69 stimulation in neutrophils induces Ca2+ influx and enhances lysozyme release, suggesting a role in granule exocytosis via a Ca2+-dependent mechanism.\",\n      \"method\": \"Flow cytometry of surface vs. intracellular CD69, cycloheximide and brefeldin A treatment, immunoprecipitation, Ca2+ flux measurement, lysozyme release assay\",\n      \"journal\": \"Cellular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological inhibitors to define intracellular localization, functional Ca2+ and degranulation readouts; single lab\",\n      \"pmids\": [\"1586955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Chimeric domain-swap analysis between CD69 and CD23 showed that the neck region (Cys68) is important for CD69 dimerization. The cytoplasmic domain of CD69 independently determines the type of signal transduced (Ca2+-dependent extracellular Ca2+ uptake and TNF-α synthesis), regardless of receptor oligomerization state. CD69 cytoplasmic domain-mediated TNF-α production was additive to FcεRI-mediated TNF-α in mast cells.\",\n      \"method\": \"CD69/CD23 chimeric receptor construction and functional expression in RBL-2H3 and Jurkat cells, Ca2+ flux measurement, serotonin release assay, TNF-α synthesis assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-swap chimeras with multiple functional readouts; single lab\",\n      \"pmids\": [\"11034393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CD69 surface expression on skin-infiltrating CD8 T cells (regulated by local antigen stimulation and type I IFNR signaling) coincides with transcriptional downregulation of S1PR1 and is a critical determinant of prolonged T cell retention and local memory T cell formation in peripheral tissues.\",\n      \"method\": \"Flow cytometry and gene expression analysis of CD8 T cells in skin, CD69-/- mouse model, type I IFNR signaling manipulation, tissue retention and memory formation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined mechanistic pathway (S1PR1 transcriptional downregulation), multiple regulatory inputs tested, replicated in skin tissue-residency context\",\n      \"pmids\": [\"25624457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Anti-CD69 mAb treatment attenuated T cell exhaustion and tumor progression in murine breast cancer. CD69 deficiency in tumor-bearing mice showed reduced tumor growth with increased tumor-infiltrating lymphocytes, less T cell exhaustion, and enhanced IFNγ production, indicating CD69 negatively regulates effector function of intratumoral T cells and promotes T cell exhaustion.\",\n      \"method\": \"CD69-/- mouse tumor model (4T1-luc2 breast cancer), anti-CD69 mAb treatment, flow cytometry of tumor-infiltrating lymphocytes, exhaustion marker analysis, IFNγ production measurement\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO and antibody treatment with defined exhaustion phenotype readout; single lab\",\n      \"pmids\": [\"30085193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CD69 expression on tumor-specific CD8+ T cells in tumor-draining lymph nodes controls their differentiation by regulating TOX transcription factor expression. CD69 deficiency diminished TOX expression in tumor-specific CD8+ T cells, promoting generation of functional terminally differentiated CD8+ T cells. Anti-CD69 administration combined with anti-PD-1 showed enhanced antitumor effect.\",\n      \"method\": \"CD69-/- mouse tumor model, flow cytometry and gene expression analysis in tumor-draining lymph nodes, TOX expression measurement, anti-CD69 + anti-PD-1 combination therapy\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined transcription factor (TOX) link and functional differentiation readout; single lab\",\n      \"pmids\": [\"37216576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CD69 targeting with anti-CD69 mAb induced rapid and massive mobilization of bone marrow leukocytes and hematopoietic stem and progenitor cells (HSPCs). This mobilization was inhibited by S1P desensitization with FTY720, and was accompanied by increased S1PR1 and CXCR4 expression. mTOR pathway activation (increased p70S6K, S6, 4E-BP1 phosphorylation) was detected after anti-CD69 treatment, and rapamycin inhibited anti-CD69-induced HSPC mobilization.\",\n      \"method\": \"Anti-CD69 mAb in vivo treatment, flow cytometry of mobilized BM cells, FTY720 and rapamycin pharmacological inhibition, phosphoprotein analysis by Western blot\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mAb treatment with pharmacological dissection of S1P and mTOR pathways; single lab, multiple inhibitors\",\n      \"pmids\": [\"29483712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CD69 expressed on CD4 T cells is required for their migration into asthmatic lung, and for Th2 response induction. CD69 deficiency compromised CD4 T cell migration into the asthmatic lung and reduced VCAM-1 expression, suggesting VCAM-1 involvement in CD69-dependent Th2 cell migration.\",\n      \"method\": \"CD69-/- mouse OVA-induced airway inflammation model, adoptive transfer of antigen-primed CD4 T cells, lung CD4 T cell migration analysis, VCAM-1 expression measurement, anti-CD69 mAb treatment\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO and adoptive transfer with defined migratory phenotype and VCAM-1 expression link; single lab\",\n      \"pmids\": [\"19923457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD69 deficiency in CD4 T cells increases expression of chemokines CCL-1, CXCL-10, and CCL-19, and increases expression/affinity of chemokine receptors, resulting in enhanced in vitro migration toward chemokine stimuli. In vivo, CD69-/- CD4 T cells accumulate in greater numbers in intestinal colonic lamina propria during colitis, and neutralization of these chemokines significantly decreased histopathological signs of colitis in CD69-/- mice.\",\n      \"method\": \"CD69-/- mouse competitive homing assay, DSS-induced colitis and antigen-specific transfer colitis, chemokine/receptor expression analysis, chemokine neutralization in vivo, in vitro migration assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined chemokine mechanism and in vivo rescue; single lab, multiple model systems\",\n      \"pmids\": [\"23776480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD69 mRNA expression in monocytes is induced by TGF-β and 1α,25-dihydroxyvitamin D3 as a primary target gene. Upregulation depends on Smad3 (shown by Smad3 knockdown) and on TAK1-mediated p38 MAPK activation. TGF-β and 1α,25(OH)2D3 do not influence CD69 mRNA stability; the effect is specific to monocytes and not observed in T or B cell lines.\",\n      \"method\": \"qPCR kinetics, mRNA stability assay with transcription inhibitor and 3'UTR reporter, Smad3 functional knockdown, MAPK inhibitor panel, promoter reporter assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic dissection with Smad3 KD and kinase inhibitors, multiple orthogonal methods; single lab\",\n      \"pmids\": [\"23696902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CD69 expression on Tregs increases survival after myocardial infarction in mice. CD69+ Tregs, by induction of AhR-dependent CD39 ectonucleotidase activity, induced apoptosis and decreased IL-17A production in γδT cells. Adoptive transfer of CD69+ Tregs into Cd69-/- mice after coronary ligation reduced IL-17+ γδT cell recruitment and increased survival.\",\n      \"method\": \"CD69-/- mouse coronary ligation model, adoptive transfer of CD69+ Tregs, AhR inhibition, CD39 ectonucleotidase activity assay, flow cytometry of γδT cells\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — adoptive transfer with defined AhR/CD39 mechanism, in vivo rescue; single lab\",\n      \"pmids\": [\"36066993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CD69 ligation induces apoptosis in GM-CSF-cultured eosinophils in a crosslinking-dependent manner, independent of TGF-β1. This apoptosis requires molecular crosslinking and does not correlate with eosinophil peroxidase release.\",\n      \"method\": \"Anti-CD69 mAb and F(ab)2 fragments applied to GM-CSF-cultured eosinophils, apoptosis measurement by morphology, DNA laddering, and flow cytometry, TGF-β1 neutralization, EPO release assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple apoptosis detection methods, F(ab)2 controls, TGF-β1 neutralization; single lab\",\n      \"pmids\": [\"8639899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"LPS/anti-CD69 co-stimulation-induced monocyte apoptosis involves at least three independent, non-redundant signaling pathways: (i) phospholipase A2 and lipoxygenase-mediated arachidonic acid metabolism, (ii) NO generation, and (iii) pertussis toxin-sensitive (ADP-ribosylation-dependent) G-protein events. Each pathway is necessary but insufficient alone to induce apoptosis.\",\n      \"method\": \"Inhibitors of PLA2, lipoxygenase, NO synthesis, pertussis toxin (wild-type vs. ADP-ribosylation-deficient mutant), TNF production and NO generation assays\",\n      \"journal\": \"Cellular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection with multiple pathway inhibitors and mutant toxin controls; single lab\",\n      \"pmids\": [\"8964080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"In murine macrophages, CD69 expression is not constitutive but is induced by IFN-γ plus LPS, TNF-α, or LPS alone, and is inhibited by PGE2 or dibutyryl-cAMP. Anti-CD69 mAb stimulation of macrophages in the presence of IFN-γ induces nitric oxide production and TNF-α release, and triggers elimination of intracellular Leishmania parasites.\",\n      \"method\": \"Flow cytometry of CD69 expression under various stimuli, pharmacological inhibition (PGE2, cAMP), anti-CD69 mAb stimulation, NO and TNF-α assays, Leishmania elimination assay\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible expression characterized with multiple stimuli and inhibitors, functional signaling readouts; single lab\",\n      \"pmids\": [\"9307073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal noncoding sequences (CNS1-4). CNS2 and CNS4 function as inducible enhancers in T cells. The CD69 promoter alone supports positive selection-dependent thymic expression but not mature lymphocyte expression. CNS1-4 elements interact both positively (CNS3, CNS4) and negatively (CNS1, CNS2 together) with the promoter to confer developmental-stage and lineage-specific regulation.\",\n      \"method\": \"DNase I hypersensitivity mapping, chromatin immunoprecipitation for epigenetic modifications, transient transfection reporter assays, transgenic mouse analysis with CNS combinations\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple regulatory elements tested in vivo and in vitro; single lab with multiple approaches\",\n      \"pmids\": [\"19841192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CD69 deficiency in mice promotes a prothrombotic phenotype with increased plasma VWF content and activity, increased VWF expression in brain vessels, and greater fibrinogen accumulation in ischemic brain tissue after stroke. Ischemia upregulated Cd69 mRNA in brain endothelial cells. This worsening effect was not attributable to lymphocytes or other hematopoietic cells (shown by chimeric mice). Blocking VWF reduced infarct volume and reversed the detrimental effect of CD69 deficiency, indicating CD69 acts as a downregulator of endothelial activation.\",\n      \"method\": \"CD69-/- and chimeric mice with MCAO stroke model, endothelial cell sorting and mRNA analysis, VWF ELISA and activity assay, fibrin(ogen) immunostaining, VWF-blocking antibody treatment\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific chimeras to attribute endothelial function, VWF rescue experiment, multiple readouts; single lab\",\n      \"pmids\": [\"30582456\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD69 is a type II transmembrane C-type lectin homodimer that functions as a signaling receptor and cis-interacting regulator of multiple membrane proteins: it physically associates with and acts as a protein agonist of S1PR1 (via its transmembrane helix contacting S1PR1-TM4, inducing Gi-coupled receptor internalization and degradation to inhibit lymphocyte egress), interacts with the amino acid transporter complex LAT1-CD98 to control L-tryptophan uptake and AhR-dependent IL-22 secretion, and associates via its cytoplasmic tail with the Jak3/Stat5 pathway to limit Th17 differentiation; upon crosslinking, CD69 signals through a Src-Syk-PLCγ2-Vav1 cascade activating ERK, Ca2+ influx, and degranulation in NK cells, and drives IL-2/IFN-γ gene expression and proliferation in T cells; natural extracellular ligands include galectin-1 and the S100A8/S100A9 complex (in a glycosylation-dependent manner), and the molecule additionally regulates endothelial VWF expression, thymocyte/lymphocyte egress from lymphoid organs, and Treg suppressive function through AhR-dependent CD39 ectonucleotidase activity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CD69 is a type II transmembrane C-type lectin glycoprotein, expressed as a phosphorylated disulfide-linked homodimer, that functions as an early activation antigen and cis-acting regulator of lymphocyte migration and effector programs across multiple leukocyte lineages [#11, #8]. Its best-defined molecular role is as a cis protein agonist of the egress receptor S1PR1: CD69 physically complexes with S1PR1 (but not S1PR3) through an integral-membrane interaction in which the CD69 transmembrane helix contacts S1PR1-TM4, allosterically activating the receptor, driving Gi-dependent internalization and degradation, and abolishing S1P gradient sensing to retain lymphocytes in lymphoid organs and peripheral tissues [#0, #1, #2, #17]. Acting downstream of type I interferon signaling, this CD69–S1PR1 axis governs thymocyte export and tissue-resident memory T cell formation [#1, #13, #17]. Beyond S1PR1, CD69 associates with additional membrane partners to shape T cell fate: it binds the LAT1-CD98 amino acid transporter to control L-tryptophan uptake and AhR-dependent IL-22 secretion, and its cytoplasmic tail engages the Jak3/Stat5 pathway to restrain RORγt-driven Th17 differentiation [#3, #4]. CD69 recognizes natural extracellular ligands—galectin-1 and the S100A8/S100A9 complex—in a carbohydrate- and glycosylation-dependent manner, linking ligand engagement to Th17 suppression and Treg generation [#5, #6]. Upon antibody crosslinking CD69 transduces an activating signal through a Src-family/Syk–PLCγ2–Vav1 cascade that activates ERK and Ca2+ influx to drive NK cell degranulation and cytotoxicity, and—together with PKC co-stimulation—IL-2/IFN-γ gene expression and T cell proliferation [#7, #9, #10]. Functionally, CD69 negatively regulates antitumor T cell effector function and exhaustion via TOX, modulates Treg suppression through AhR-dependent CD39, and downregulates endothelial VWF expression to limit thrombosis [#18, #19, #24, #29].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Established that CD69 is not merely an activation marker but a signaling receptor by showing that its crosslinking transduces a defined activating signal in T cells.\",\n      \"evidence\": \"Anti-CD69 mAb crosslinking with Ca2+, cytokine gene expression, and proliferation readouts in T cells\",\n      \"pmids\": [\"2501389\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the proximal kinases or adaptors\", \"PKC co-stimulation requirement left the autonomous signaling capacity undefined\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Defined the physical nature of CD69 as a phosphorylated disulfide-linked homodimer and showed its signaling extends beyond lymphocytes to platelet activation.\",\n      \"evidence\": \"Biochemical characterization and anti-CD69 crosslinking aggregation/degranulation assays in human platelets\",\n      \"pmids\": [\"2388032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No molecular receptor or downstream pathway resolved\", \"Physiological ligand on platelets unknown\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Provided the foundational molecular identity—cloning revealed CD69 as a type II C-type lectin glycoprotein related to NK receptor families, framing all later structure-function work.\",\n      \"evidence\": \"cDNA cloning, functional COS-7 expression, chromosomal mapping, homology analysis\",\n      \"pmids\": [\"8340758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No natural ligand identified at this stage\", \"Lectin domain glycan specificity unresolved\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Connected CD69 induction to TCR signaling biochemistry by placing p21ras activation upstream of CD69 surface expression.\",\n      \"evidence\": \"Constitutively active and dominant-negative Ras constructs with GTP-Ras IP and AP-1 reporter in Jurkat cells\",\n      \"pmids\": [\"7907294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcription factors directly driving the CD69 promoter not defined here\", \"Relationship of Ras pathway to lineage-specific expression unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Dissected the CD69 outgoing signaling cascade in NK cells, identifying Src→Syk→PLCγ2/Vav1 as the effector axis for cytotoxicity.\",\n      \"evidence\": \"Anti-CD69 crosslinking with IP/kinase assays, Src/Syk inhibitors, and cytotoxicity readouts in IL-2-activated NK cells\",\n      \"pmids\": [\"12077230\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cytoplasmic adaptor linking CD69 to Src/Syk not identified\", \"How the short cytoplasmic tail nucleates kinase recruitment unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated genetically that CD69 controls thymocyte egress, separating its retention function from any role in maturation or selection.\",\n      \"evidence\": \"Dose-dependent CD69 transgenic mouse with thymic export quantification and selection/signaling controls\",\n      \"pmids\": [\"12039905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of retention not yet identified (pre-S1PR1 discovery)\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified the central mechanistic partner—CD69 physically complexes with S1PR1 to downmodulate it, explaining lymphocyte retention downstream of type I IFN.\",\n      \"evidence\": \"Co-IP, coexpression chemotaxis assays, CD69-/- mice with poly(I:C)/LCMV, CD69-CD3ζ chimera reporter\",\n      \"pmids\": [\"16525420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interface residues and structural basis unknown\", \"Whether interaction is direct or requires accessory proteins unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Mapped the CD69–S1PR1 interaction to transmembrane/membrane-proximal domains and S1PR1-TM4, and linked it to S1PR1 degradation and a ligand-bound-like conformation.\",\n      \"evidence\": \"CD69/NKRp1A domain swaps, S1PR1 mutagenesis, radioligand binding, T cell egress assays\",\n      \"pmids\": [\"20463015\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of the complex not yet resolved\", \"Mechanism of CD69-induced degradation not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed a cytoplasmic-tail signaling function: CD69 engages Jak3/Stat5 to restrain Th17 differentiation, broadening its role from migration to T cell fate.\",\n      \"evidence\": \"Co-IP of CD69 tail with Jak3/Stat5, in vitro Th17 differentiation of CD69-/- cells, Jak3 inhibition, IL-2 rescue, in vivo models\",\n      \"pmids\": [\"20696842\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between cytoplasmic tail and Jak3 not mapped\", \"Whether association is constitutive or ligand-induced unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified galectin-1 as a bona fide carbohydrate-dependent ligand of CD69, providing a physiological trigger for its Th17-suppressive function.\",\n      \"evidence\": \"CD69-ECD pulldown + MS, surface plasmon resonance, blocking antibodies, Th17 assays\",\n      \"pmids\": [\"24752896\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling triggered by galectin-1 engagement not dissected\", \"Affinity in physiological membrane context uncertain\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified the S100A8/S100A9 complex as a second natural ligand and showed CD69 N-glycan sialylation gates ligand-driven Treg generation via SOCS3/STAT3.\",\n      \"evidence\": \"IP-MS, in vitro binding/competition, glycomics, CD69 RNAi, STAT3 signaling readouts in human PBMCs\",\n      \"pmids\": [\"26296369\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab findings without independent replication\", \"How glycan editing is regulated in vivo unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Tied CD69 surface expression to tissue-resident memory formation by linking it to S1PR1 transcriptional downregulation and prolonged peripheral retention.\",\n      \"evidence\": \"Flow/gene expression of skin CD8 T cells, CD69-/- mice, type I IFNR manipulation, retention/memory assays\",\n      \"pmids\": [\"25624457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism coupling CD69 to S1PR1 transcriptional repression not defined\", \"Generality across non-skin tissues not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovered a metabolic regulatory function: CD69 associates with LAT1-CD98 to control tryptophan uptake and AhR-dependent IL-22, linking it to psoriasis.\",\n      \"evidence\": \"Co-IP, transporter surface flow cytometry, metabolite measurement, CD69-/- psoriasis model with in vivo rescue\",\n      \"pmids\": [\"27376471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural basis of the CD69–LAT1-CD98 interaction unknown\", \"Whether the same complex operates in other T cell subsets unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided the atomic mechanism: cryo-EM showed CD69-TM contacts S1PR1-TM4 to allosterically activate the receptor and engage Gi, establishing CD69 as a cis protein agonist.\",\n      \"evidence\": \"Cryo-EM of CD69–S1PR1–Gi, interface mutagenesis, receptor internalization assays\",\n      \"pmids\": [\"37039481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure does not capture the degradation/trafficking step\", \"How CD69 dimer asymmetry is regulated in cells unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected CD69 to tumor T cell differentiation by showing it controls TOX expression, defining a checkpoint-combinable target.\",\n      \"evidence\": \"CD69-/- tumor model, TOX expression analysis in tumor-draining lymph nodes, anti-CD69 + anti-PD-1 therapy\",\n      \"pmids\": [\"37216576\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study without independent replication\", \"Molecular link between CD69 signaling and TOX transcription not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CD69's multiple cis membrane interactions (S1PR1, LAT1-CD98), its glycan-dependent ligand engagements, and its cytoplasmic Jak3/Stat5 coupling are integrated and switched within a single cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of how one CD69 dimer partitions among distinct partner complexes\", \"Cytoplasmic tail adaptor(s) coupling CD69 to Src/Syk and Jak3 not biochemically identified\", \"Quantitative rules governing glycosylation-dependent ligand selectivity unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [7, 9, 10]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 8, 11]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 7, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 4, 13, 17]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [1, 2, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"S1PR1\", \"SLC7A5\", \"SLC3A2\", \"JAK3\", \"STAT5\", \"LGALS1\", \"S100A8\", \"S100A9\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}